Matches in Nanopublications for { ?s ?p "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP992643.RAaKkeDBF0CtHoNL8nLi9JZZtwyXXBtpxPjqnT4YUEHS8130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992643.RAaKkeDBF0CtHoNL8nLi9JZZtwyXXBtpxPjqnT4YUEHS8130_provenance.
- NP993050.RAUoVw6pLH2l6fklkBki8Ro2xEtQ_8KwHlq_dGfqfVpos130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993050.RAUoVw6pLH2l6fklkBki8Ro2xEtQ_8KwHlq_dGfqfVpos130_provenance.
- assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP993192.RAmiu0j0VOMBudCyL-S5CzW5jWiJIzJRjsTBGWYx4dgOI130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993192.RAmiu0j0VOMBudCyL-S5CzW5jWiJIzJRjsTBGWYx4dgOI130_provenance.
- NP1104416.RAmrOYoLPVmLbWuGipwJGyyxAba6kt4KL9oH4-FW5UMLw130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104416.RAmrOYoLPVmLbWuGipwJGyyxAba6kt4KL9oH4-FW5UMLw130_provenance.
- NP1104417.RAkYaqA-yAuigwY5KXtTVsoUWZ9T2YsXIlH3IJhp0AiR0130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104417.RAkYaqA-yAuigwY5KXtTVsoUWZ9T2YsXIlH3IJhp0AiR0130_provenance.
- NP1104418.RAmkHDTef5LcHN51Six1id5MCeEkYjl3zH-6_8VUwYDmo130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104418.RAmkHDTef5LcHN51Six1id5MCeEkYjl3zH-6_8VUwYDmo130_provenance.
- NP992618.RA1s2tO3Xv6vLU9I2CqQx4jIXlAcfC8bwOj8qyw-kQo8o130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992618.RA1s2tO3Xv6vLU9I2CqQx4jIXlAcfC8bwOj8qyw-kQo8o130_provenance.
- NP1104419.RA12Oncm29SSx__aJpy8sERfc7epooqNbRA-G77YyO28I130_assertion description "[Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104419.RA12Oncm29SSx__aJpy8sERfc7epooqNbRA-G77YyO28I130_provenance.